Revolution Medicines (RVMD) stock gained after the FDA granted early approval to Rasonque for pancreatic cancer, with trial data showing significant survival benefits. The post Revolution Medicines (RVMD) Stock Climbs After Early FDA Green Light for Pancreatic Cancer Treatment ap...
Revolution Medicines (RVMD) Stock Climbs After Early FDA Green Light for Pancreatic Cancer Treatment
其他语言标题
- 한국어레볼루션 메디신스(RVMD) 주가, 췌장암 치료제에 대한 FDA 조기 승인 이후 상승